Loading...
Pulmonary arterial hypertension: molecular genetic basis and emerging treatments
Siddiqui, M.A. Ogo, T. Nasim, Md. Talat
Siddiqui, M.A.
Ogo, T.
Nasim, Md. Talat
Publication Date
2012
End of Embargo
Supervisor
Rights
© 2012 AKMMC Journal. Full-text reproduced in accordance with the publisher's self-archiving policy.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Pulmonary arterial hypertension (PAH) is a rare cardiovascular disorder caused by narrowing of blood vessels in the lung and in the absence of therapy leads to right heart failure and death. No cure for this devastating disorder is known. The major objective of the current treatments is to improve symptoms and these therapies were developed prior to the discovery that this disease has substantial genetic components. In this review, we discuss molecular genetic basis of PAH together with pathobiology, current and future therapeutic interventions.
Version
Accepted manuscript
Citation
Siddiqui MA, Ogo T and Nasim MT (2012) Pulmonary arterial hypertension: molecular genetic basis and emerging treatments. Anwer Khan Modern Medical College Journal. 3(2): 30-33.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article